Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients

Brain Injury

Volumn 23, Issue 13-14, 2009, Pages 1065-1072

  Matsumoto, Shuji ^a   Shimodozono, Megumi ^a   Miyata, Ryuji ^a   Kawahira, Kazumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cerebral blood flow; Cerebrovascular reserve capacity; Hypertension; Olmesartan; Stroke

Indexed keywords

OLMESARTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BRAIN; BRAIN BLOOD FLOW; BRAIN HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; SCORING SYSTEM; STROKE PATIENT; THERAPY EFFECT;

EID: 70450200272     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699050903379404     Document Type: Article

References (34)

1. Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. British Medical Journal 1973;1:507-510.
2. Kuriyama Y, Sawada T, Omae T. Anitihypertensive drugs and cerebral circulation. In: Omae T, Zanchetti A, editors. How should elderly hypertensive patients be treated? Springer: Tokyo; 1989. pp 69-81.
3. Barry DI, Jarden JO, Paulson OB, Graham DI, Strandgaard S. Cerebrovascular aspects of converting-enzyme inhibition. I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats. Journal of Hypertension 1984;2: 589-597.
4. Jarden JO, Barry DI, Juhler M, Graham DI, Strandgaard S, Paulson OB. Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril. Journal of Hypertension 1984;2:599-604.
5. Paulson OB, Jarden JO, Vorstrup S, Holm S, Godtfredsen J. Effect of captopril on the cerebral circulation in chronic heart failure. European Journal of Clinical Investigation 1986;16: 124-132.
6. Oku N, Kitagawa K, Imaizumi M, Takasawa M, Piao R, Kimara Y, Kajimoto K, Matsumoto M, Hori M, Hatazawa J. Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertension Research 2005;28:43-48.
7. Meyer JS, Shinohara T, Imai A, Kobari M, Sakai F, Hata T, Oravez WT, Timpe GM, Deville T, Solomon E. Imaging local cerebral blood flow by xenon-enhanced computed tomography: Technical optimization procedures. Neuroradiology 1988;30:283-292.
8. Gur D, Yonas H, Good WF. Local cerebral blood flow by xenon-enhanced CT: Current status, potential improvements, and future directions. Cerebrovascular and Brain Metabolism Reviews 1989;1:68-86.
9. Nogami K, Fujii M, Kato S, Nishizaki T, Suzuki M, Yamashita S, Oda Y, Sadamitsu D, Maekawa T. Analysis of magnetic resonance imaging (MRI) morphometry and cerebral blood flow in patients with hypoxic-ischemic encephalopathy. Journal of Clinical Neuroscience 2004;11: 376-380.
10. Pindzola RR, Balzer JR, Nemoto EM, Goldstein S, Yonas H. Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced CT cerebral blood flow and transcranial Doppler. Stroke 2001;32:1811-1817.
11. Tomura N, Sasaki K, Kidani H, Nishii T, Yasuda K, Ishiyama K, Otani T, Sakuma I, Takahashi S, Watarai J, et al. Reduced perfusion reserve in leukoaraiosis demonstrated using acetazolamide challenge 123I-IMP SPECT. Journal of Computer Assisted Tomography 2007;31:884-887.
12. Okudaira Y, Nakanishi H, Arai H, Sato K. Differences in acetazolamide vasoreactivity in patients with acute and chronic occlusion of the internal carotid artery. Journal of Clinical Neuroscience 2003;10:316-319.
13. Moriwaki H, Uno H, Nagakane Y, Hayashida K, Miyashita K, Naritomi H. Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stoke. Journal of Human Hypertension 2004;18:693-699.
14. Kretschmann HJ, Weinrich W. Neuroanatomy and cranial computed tomography. New York: Thieme; 1986.
15. Brunnstrom S. Movement therapy in hemiplegia: A neurophysiological approach. New York: Harper & Row; 1970.
16. Mahoney F, Barthel D. Functional evaluation: The Barthel index. Maryland State Medical Journal 1965;14:61.
17. Folstein M. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189.
18. Miura S, Fujino M, Hanzawa H, Kiya Y, Imaizumi S, Matsuo Y, Tomita S, Uehara Y, Karnik SS, Yanagisawa H, et al. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. Journal of Biological Chemistry 2006;281:19288-19295.
19. Smith DH, Dubiel R, Jones M. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan. American Journal of Cardiovascular Drugs 2005;5:41-50.
20. Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. Journal of Clinical Hypertension 2001;3:283-291.
21. Ishikawa J, Kario K, Hoshige S, Eguchi K, Morinari M, Kaneda R, Umeda Y, Ishikawa S, Kuroda T, Hojo Y, et al. J-MORE Study Group. Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study. American Journal of Hypertension 2005;18:958-965.
22. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Pressure Monitoring 2001;6:63-72.
23. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003;107:1401-1406.
24. Bommer WJ. Use of angiotensin-converting enzyme inhibitor/ angiotensin II receptor blocker therapy to reduce cardiovascular events in high-risk patients: Part 1. Preventive Cardiology 2008;11:148-154.
25. Ogasawara K, Ogawa A, Terasaki K, Shimizu H, Tominaga T, Yoshimoto T. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: Comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. Journal of Cerebral Blood Flow and Metabolism 2002;22:1142-1148. (Pubitemid 35006807)
26. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000;31:2478-2486.
27. Vraamark T, Waldemar G, Strandgaard S, Paulson OB. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. Journal of Hypertension 1995;13: 755-761.
28. Stromberg C, Naveri L, Saavedra JM. Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. Journal of Cerebral Blood Flow and Metabolism 1993;13:298-303.
29. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe- Pedersen O, et al. LIFE Study Group. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomized trial against atenolol. Lancet 2002;359:995-1003. (Pubitemid 34286536)
30. Jorgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Stolier M, Olsen TS. Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen stroke study. Archives of Physical Medicine and Rehabilitation 1995;76:406-412.
31. Howanitz EM, Wisotzek IE, Losonczy MF, Schaffer C. The relationship between mental status examination scores and cerebral blood flow in geriatric schizophrenia. Schizophrenia Research 2001;49:228-229.
32. Kitagawa Y, Meyer JS, Tachibana H, Mortel KF, Rogers RL. CT-CBF correlation of cognitive deficits in multi-infarct dementia. Stroke 1984;15:1000-1009.
33. Rogers RL, Meyer JS, Mortel KF, Mahurin RK, Judd BW. Decreased cerebral blood flow precedes multi-infarct dementia, but flows senile dementia of Alzheimer type. Neurology 1986;36:1-6.
34. Ullman JS, Bederson JB. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes. Critical Care Clinics 1996;12: 697-707.